Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2012
November 1, 2012
- Pfizer Appeals CEO Appearance at Chantix Trial
- GSK Celebrates 40 Years of Pharmaceutical Manufacturing in Singapore
- Vertex Enters Agreement with GlaxoSmithKline for Phase 2 All-Oral Study of VX-135 and GSK2336805 for the Treatment of Hepatitis C
- Teva Reports Third Quarter 2012 Results
- ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million
- Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
- Pfizer Reports Third-Quarter 2012 Results
- Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
- Flu Vaccine May Reduce Heart Disease Risk
- Study Links Pregnancy Risks, Antidepressants
- FDA Has Safety Concerns Over Biocryst's Hep C Drug
- Drugs Giant Backs BMJ Calls for Full Disclosure of Trial Data: GSK Supports
- Lilly to Expand Indianapolis Insulin Manufacturing Operations
- J&J Restoring Cancer Drug Supply to EU Patients
- Ensemble Therapeutics and Boehringer Ingelheim Initiate Collaboration to Discover Macrocycle Drug Candidates
- Baxter Announces Long-Term Partnership in Brazil to Expand Access to Recombinant FVIII Hemophilia Treatment
- Lilly Statement on Hurricane Sandy Relief Efforts
- Eli Lilly Plans $140M Expansion of Insulin Plant
November 2, 2012
- Bristol-Myers Squibb Receives Positive Decision from National Institute of Health and Clinical Excellence (NICE) for YERVOY (ipilimumab)
- Portola, Bristol-Myers Squibb and Pfizer Sign Clinical Collaboration Agreement to Study ELIQUIS and Portola's Universal Factor Xa Inhibitor Antidote PRT4445
- Merck Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit Related to Vioxx
- Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001
- Rep. Markey Announces Legislation to Strengthen Compounding Pharmacy Regulations
- VWR International, LLC Acquires Lab3 Limited in the UK
- Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events
- Public Communication - Health Canada Endorsed Important Safety Information on Infanrix Hexa
November 5, 2012
- Bioniche Life Sciences Inc. Announces Discontinuation of Current Phase III Clinical Trial with Urocidin
- Merck Will Initiate Interferon-Free Phase II Clinical Trials for MK-5172, an Investigational, Once-Daily, Oral Treatment for Chronic Hepatitis C Virus
- Eli Lilly Japan and Chugai to Terminate Co-Marketing Agreement of ?Evista Tablet 60mg,? a Treatment for Osteoporosis in Postmenopausal Women
- Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
- Novartis Cancer Drug Receives EU OK for New Use
- Isis Announces Expedited Development Of ISIS-TTR Rx And Amendment To The Collaboration With GSK To Support Phase 2/3 Study
- Teva Announces Changes to Executive Leadership Team
- New Study Finds Pharmacists Play an Increasingly Active Role in Patient Care and Show Strong Demand for Digital Patient Support Resources from Pharma
- Six New Plaintiffs Join Sanford Heisler's $100m Gender Discrimination Class Action Against Forest Laboratories & Forest Pharmaceuticals
- Did Sun and Taro Under-Report 3rd Quarter Results by Gaming Reserves?
- Ligand Pharmaceuticals Reports Preliminary Third Quarter 2012 Results
- Ligand Pharmaceuticals to Restate Previous Financial Statements
November 7, 2012
- FDA Rejects Petition to Remove High Aricept Dose
- Novo Nordisk Falls on FDA Insulin Review
- Auxilium and Pfizer Will Conclude Agreement on Xiapex EU Collaboration
- Firms' Use of Citizen Petitions Against Generics Debated
November 8, 2012
- Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.
- Boehringer Recalls Manufacturing Lot of Pradaxa
- Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds
- Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
- XenoPort and GlaxoSmithKline Mutually Agree to Terminate Their Collaboration on Horizant
- Merck and Regenstrief Institute Establish Evidence-Based Care Collaboration
- Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
- Ranbaxy Delivers Strong Overall Business Performance; Improvement in Base Business Sales and Margins
- MorphoSys Announces Expansion of Antibody Alliance
- Supreme Court Ruling Paves the Way for Generic Version of Viagra - Teva Canada to Sell Sildenafil Tablets in Canada
- Mylan Announces Ortho Tri-Cyclen Lo Settlement Agreement
November 9, 2012
- High Court OKs Move to Produce Generic Viagra
- FDA Panel Votes 8-4 for Novo Nordisk Diabetes Drug
- Italian Authorities Lift Precautionary Hold on Novartis Seasonal Influenza Vaccines
- Chiromics and Bristol-Myers Squibb Form Drug Discovery Strategic Alliance
- NICE Consults on Treatment for Asthma in Children and Adults
- Chiromics and GlaxoSmithKline Enter into Collaboration
- Indegene to Acquire the Multi-channel, e-Detailing and Physician Marketing Services Business Assets of Canada-based Aptilon, to Help Clients Accelerate Their Physician Engagement Strategies
November 12, 2012
- Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration
- Pfizer's Xeljanz Story Reveals Why New Drugs Are So Costly
- Teva Wins Viagra Patent Case in Canada
- Pluristem Shares Bounce Back After Thursday Plunge
November 13, 2012
- Neptune Provides Update on Incident at Its Production Plant
- Generic Competition Grows for Pfizer's Revatio
- Celgene Rises on Abraxane Pancreatic Cancer Data
- Vivus Says Qsymia Ingredients Help Sleep Apnea
- Nektar Shares Fall on Regulatory Approval Concerns
- FDA Sends Letter to Cornerstone Regarding Press Release
- Abbott Announces Phase 3 Hepatitis C Program Details
- Genzyme Announces Return to Full Supply of Thyrogen (thyrotropin alfa for injection)
November 14, 2012
- Liberal Group Outlines $385B in Medicare Cuts
- Actress Elizabeth Perkins and Sanofi US Announce Nationwide Casting Call for Diabetes Co-Stars Documentary
- Canada Prepares for Drug Patent Concessions to Clinch Free-Trade Deal With EU
- Analysts Tout Advantage of Gilead Hepatitis C Drug
- Pernix Therapeutics Announces Agreement to Acquire Cypress Pharmaceuticals, Inc. and Hawthorn Pharmaceuticals, Inc.
- Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
- Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer's Disease
- Governor Cuomo Announces Regeneron Pharmaceuticals to Expand in The Capital Region
- Perspective on Innovation 2012: Bayer: Improving People?s Lives Through Innovation
- Ill. Governor Quinn Announces Durata Therapeutics Moves to Chicago
November 15, 2012
- Q3 2012: Merck?s Good Performance Continues During Transformation
- Astellas Received the Notice from AstraZeneca Not to Exercise the Option to Acquire Diabetes Assets from Prosidion, a Subsidiary of Astellas
- PwC Report Forecasts a Golden Era Ahead for Pharmaceutical Companies, but Global Growth Markets Won't Guarantee Success
- Thai Delegate Killed at Glasgow Conference
- Janssen Research & Development Announces Establishment of Global Cross-Pharmaceutical Clinical Trial Investigator Databank
- Drugmakers Collaborate to Facilitate Drug Tests
November 16, 2012
- Manhattan Research Releases Competitive Review of Online Pharma Promotion Campaigns ? 36 Pharma Companies Covered
- Tranzyme Shares Plummet After Drug Trial Disappoints
- Doctor Accused of Taking Kickbacks to Prescribe Anti-Psychotic Drug
- Teva Settles Copaxone ALS Clinical Trial Case
- LaVoie Group Adds Analytics Software Company to Client Roster
November 19, 2012
- Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
- Medimmune Creating Drug Pipeline for AstraZeneca
- Teva, AstraZeneca Reportedly Competing to Court Amarin
- Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
- New Study Shows 72 Percent of European Online Consumers are Social Health Users
- New Study Shows 72 Percent of European Online Consumers are Social Health Users
- Harrison and Star?s specialty focus front and center in rebranding
- SEC Charges Ring of High School Buddies with Insider Trading in Health Care Stocks
November 20, 2012
- Researcher: Medical Ethics Must Carry to Social Media
- Lawmaker Warns of Drug Companies' Ties With D.C. Doctors
- FDA Sends Letter to Alcon Research Regarding Sales Aid
- Twenty six percent of online adults discuss health information online; privacy cited as the biggest barrier to entry
- Sudler & Hennessey Launches New Business Consulting Group
- Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs
November 21, 2012
- UCB and Newbridge Pharmaceuticals Partner for Middle East and African Markets
- Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
November 26, 2012
- Generic Lipitor Doses Recalled for Glass Fears Health
- Sucampo and Abbott Announce Launch of AMITIZA in Japan
- MAP Shares Up After New Drug Application Accepted
- Report: Baxter Trying to Buy Swedish Device Maker
- Pfizer Drops Viagra Canada Price Due to Generics
- Ranbaxy Launches Absoricatm (Isotretinoin) Capsules in the U.S. Healthcare Market
- UCB to Enter Into An Asset Purchasing Agreement With Exemed Pharmaceuticals for Its Indian Manufacturing Facility
- Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence
November 27, 2012
- Seattle Genetics Drug Gets New Orphan Drug Review
- Transcept Pharmaceuticals Announces Broadened Intermezzo Commercialization Strategy Including Initiation of a Direct to Consumer Advertising Campaign by Purdue Pharma
- Abbott's Humira (Adalimumab) Approved in Europe for Severe Active Pediatric Crohn's Disease
- Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
- New Study Finds Formulary Decision Makers Show Strong Demand for Digital Resources from Pharma for Key Decision-Making
November 28, 2012
- Report Finds Big Pharma is Doing More for Access to Medicine in Developing Countries than Two Years Ago
- Novartis Highlights Key Data in Patients With Hematologic Diseases and Breast Cancer With More Than 140 Abstracts at ASH and SABCS
- Big Pharma Ups Its Game in Providing Drugs to People in Poor Countries
- Pfizer Acquires NextWave Pharmaceuticals, Inc.
- Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
- AccentHealth Expands Point-of-Care Network with Acquisition of Havas? Impact Wallboard Business
- Klick Health brings home Technology Optimization and Innovation Award
November 29, 2012
- Bayer Supports Pharmaceutical Research in Europe
- Forest Laboratories, Inc. Announces Additional Settlement Agreements in BYSTOLIC Patent Litigation
- Abbott Directors Approve AbbVie Split
- Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings
- Abbott Board of Directors Approves Separation of AbbVie and Declares Special Dividend Distribution of AbbVie Stock
- FDA Statement on the Ranbaxy Atorvastatin Recall
- Monthly News Round Up - November 2012
November 30, 2012
- FDA Panel Backs J&J Tuberculosis Drug
- 150 Years of Bayer: Success through Innovation and Change
- BioCryst Pharmaceuticals and Presidio Pharmaceuticals Mutually Terminate Merger Transaction
- Biogen Idec Opens New RTP Facility
- AMRI Realigns Discovery Services to Support Customer Demand
- pSivida Corp. Reports Patient Access Scheme Being Developed by Alimera to Address Cost Concerns Following Negative Final Draft Guidance by U.K.'s NICE for ILUVIEN for DME
